Philogen SpA (MIL:PHIL) Accounts Payable : €9.55 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Accounts Payable?

Philogen SpA's Accounts Payable for the quarter that ended in Dec. 2024 was €9.55 Mil.

Philogen SpA's quarterly Accounts Payable increased from Dec. 2023 (€7.80 Mil) to Jun. 2024 (€8.92 Mil) and increased from Jun. 2024 (€8.92 Mil) to Dec. 2024 (€9.55 Mil).

Philogen SpA's annual Accounts Payable increased from Dec. 2022 (€6.35 Mil) to Dec. 2023 (€7.80 Mil) and increased from Dec. 2023 (€7.80 Mil) to Dec. 2024 (€9.55 Mil).

Philogen SpA Accounts Payable Historical Data

The historical data trend for Philogen SpA's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Accounts Payable Chart

Philogen SpA Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

3.92

5.83

6.35

7.80

9.55

Philogen SpA Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable	Get a 7-Day Free Trial					6.35	7.97	7.80	8.92	9.55

Philogen SpA Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Philogen SpA Accounts Payable Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (MIL:PHIL) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

78Q:Germany

Address

Piazza La Lizza No. 7, Siena, ITA, 53100

Website

https://www.philogen.com

Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.